AiCure company overview
About
Expert Vetted Data
Public disclosures rarely capture a company's internal dynamics or the true state of its technology. Gain first-hand insight by speaking with former AiCure executives.
Ownership & Key Financials
Revenue
Investors
Revenue / FTE
Ownership
FTEs
Key Business Breakdowns
Products & Services
AiCure Site Services
•••••••••••• •••••••• ••• ••••• ••••••••/••••• •••••••••• •••••• •• •••• •••••••••••••• ••• ••••••••••.
Interactive Coaching and Engagement
••-•••••• ••••••• •••••••••• •••••••• ••••••••• ••••••••••• •••••••, ••••••••, ••• •••••••••••• •• ••••••••• •••••••••.
AiCure Data Intelligence Platform
•••-••••• ••••••••• •••••••• ••••••••••• ••• ••••••••• ••••••• •••• ••••••••• ••• •••••• ••••.
AiCure Patient Connect™
••••••'• •••••••• •••••• ••••••••••• ••• ••••••••, •••••••••• •••••••• •••••• (••• •••••••••• •••••••) •• ••••••• •••••••••• •••••••••.
Advanced AI & Intellectual Property
•••••••••• •• •••••• •••••••••• •••••••• ••••••, ••••••• ••••••••, ••• •••••••••• •••••••• •••• ••••••••• •• ••• •••••• •••••••••.
Pricing & Go-to-market
Pricing model
Project-based pricing, with fees determined by factors such as patient volume, number of clinical sites, geographic scope, trial duration, and selecte• •••••••• ••••••••.
Average Sales Value
•. $•••• •••••• ••• •••••••••••••• ••••••••• ••• •. $••• ••• •••••• •••••• ••••••• ••• •••••••••.
Growth Review
Customer Overview
•. •• •••••••••, ••• •••••••• •• ••••• ••• •• ••• •••••••••••••• ••••••••.
Customer Concentration
••• ••• •• ••••••••• •••••••••• •. ••% •• ••••• •••••••.
Customer Retention
••-••%.
Barriers to Switching
•••• • ••••••• •• ••••• ••••, ••••••••• ••••• •• ••••• ••••••• ••• •••.
| Company Name | Revenue | FTE | Proprietary Insights | HQ | Ownership Type |
|---|---|---|---|---|---|
| | - | •• '•• | - | USA | P•••••••• |
| | - | - | - | - | - |
| | - | - | - | - | - |
| | - | - | - | - | - |
| S Saama | - | - | - | - | - |
| | - | - | - | - | - |
| | - | - | - | - | - |
| | - | - | - | - | - |
| | - | - | - | - | - |
| | - | - | - | - | - |
| | - | - | - | - | A••••••• |
| | - | - | - | - | - |
| | - | - | - | - | - |
Experts highlight AiCure's operational execution and market approach, while noting market evolution and timing considerations as a potential constraint.
What does Origin provide on AiCure?
Origin provides a structured company snapshot of AiCure, combining expert-led insights with analysis across business model, customers, competitors, and market dynamics. The profile is designed to support research, competitive analysis, and commercial due diligence workflows.
How is Origin's analysis of AiCure different from traditional company databases?
Traditional company databases often focus on surface-level metadata such as ownership, funding, and company descriptions. Origin complements these sources with qualitative insights informed by expert interviews, helping teams understand how AiCure operates, competes, and creates value in practice.
Is Origin suitable for researching private companies like AiCure?
Yes. Origin is built to support research on private companies, where public information can be limited or inconsistent. It focuses on insight depth and operational context, which can be useful when evaluating companies like AiCure for investment, partnership, or competitive analysis.
Where does Origin's information on AiCure come from?
Origin insights are derived from expert interviews conducted by Dialectica, combined with structured analysis and secondary validation where appropriate. This approach prioritises first-hand operational perspectives alongside supporting evidence, rather than relying solely on aggregated public data.
Can Origin support commercial due diligence on AiCure?
Origin can support early-stage commercial due diligence by helping teams quickly understand positioning, value drivers, customer dynamics, and potential risks related to AiCure. It is typically used to shape hypotheses and focus areas before deeper primary research.
How does Origin compare to Crunchbase or PitchBook for analysing AiCure?
Crunchbase and PitchBook primarily focus on company metadata, ownership, funding history, and transactions. Origin complements those sources by adding qualitative, insight-led analysis focused on business fundamentals, go-to-market execution, customer reality, and competitive positioning for companies like AiCure.
How can Origin support portfolio monitoring or add-on analysis for companies like AiCure?
For PE-backed contexts, Origin can support monitoring by surfacing changes in competitive intensity, customer demand signals, and go-to-market effectiveness. It can also inform add-on analysis by clarifying adjacency opportunities and how a target like AiCure may fit within a broader platform strategy.
What does Origin typically reveal about pricing and go-to-market strategy for enterprise software companies like AiCure?
For enterprise software, Origin often focuses on pricing logic, contract structure, buyer personas, procurement friction, and channel strategy. For companies like AiCure, this can help teams assess how revenue is created, what drives expansion, and where sales cycles or retention may impact outcomes.
Relevant Companies
FinThrive
Revenue cycle management software platform for healthcare organizations to manage patient access, charge integrity, claims, contracts, and revenue recovery with integrated AI, automation, and analytics tools.
HQ
Ownership
Investors
MedPoint Digital
Healthcare technology platform for medical providers to facilitate patient engagement, manage telehealth visits, and coordinate care delivery.